USAID Freeze Sparks Concern and Uncertainty Across Africa

PHOENIX, ARIZONA - DECEMBER 22: U.S. President-elect Donald Trump smiles during Turning Point USA's AmericaFest at the Phoenix Convention Center on December 22, 2024 in Phoenix, Arizona. The annual four day conference geared toward energizing and connecting conservative youth hosts some of the country's leading conservative politicians and activists. (Photo by Rebecca Noble/Getty Images)

A three-month pause on nearly all U.S. foreign development assistance, ordered by the Trump administration, is sending ripples of concern and uncertainty across Africa, particularly impacting critical health programs and humanitarian aid. The freeze, pending a review aligned with the administration’s “America First” policy, has raised alarms among aid organizations and human rights advocates, who warn of potentially dire consequences for vulnerable populations.

The U.S., through the U.S. Agency for International Development (USAID), is the world’s largest provider of development aid. In the 2023 fiscal year, the U.S. dedicated nearly $70 billion to such assistance, making the current freeze a significant event with global implications. While some essential aid like urgently needed food assistance and life-saving medicine has been exempted, the sweeping nature of the pause has left many programs in limbo.

The impact is already being felt on the ground. In Johannesburg, South Africa, workers at U.S.-funded HIV organizations faced immediate stop-work orders. One health worker, identified only as Mary, expressed her distress to a local newspaper, stating, “I never thought I’d wake up in the morning and be told that I’d be banned from going to work.” She voiced deep concern about the impact on patients, feeling she was breaching her oath to do no harm.

This situation is reflective of a broader unease across the continent. Programs focusing on crucial areas like gender equity, business development, and the distribution of life-saving HIV medications are now facing significant disruptions. These medications, provided largely through the President’s Emergency Plan for AIDS Relief (PEPFAR), have been a cornerstone of U.S. engagement in global health and a vital pillar of its relations with developing nations.

The freeze has also drawn criticism from international bodies. The United Nations, through its spokesperson, expressed concern and called for additional exemptions to ensure the continued flow of critical development and humanitarian aid to the most vulnerable communities. The UN emphasized that lives and livelihoods depend on this support.

While the Trump administration argues that the pause is necessary for ensuring efficiency and alignment with the “America First” agenda, critics argue that pausing aid during the review process is counterproductive. Human Rights Watch, while acknowledging the importance of accountability, emphasized that pausing assistance puts vital programs and vulnerable populations at risk. They argue that true American prosperity is intertwined with supporting countries emerging from conflict and fostering democratic institutions, which are often underpinned by development assistance.

The long-term effects of this freeze remain to be seen. However, the immediate impact on essential services and the uncertainty it creates for countless beneficiaries are already a cause for serious concern across Africa.

About The Author